Main Article Content
Basal cell nevus syndrome is a rare inherited autosomal dominant syndrome characterized by developmental defects and tumor predisposition. There are more than 400 reported PTCH1 mutations, including frameshift, nonsense, missense, deletions, duplications, and splicing mutations. We report a 68-year-old Thai female presenting with multiple basal cell carcinoma scattered on the face and upper back and palmoplantar pits. Molecular diagnosis showed a novel heterozygous mutation in the splice site region c.746+1_746+4delGTAA, localized within the splice donor after exon 5 of PTCH1. Although the clinical manifestations are characteristic, this report adds another splice site mutation to the genotypic variation of BCNS patients and also highlights the importance of a multidisciplinary approach in the management of BCNS patients.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
2. Reinders MG, van Hout AF, Cosgun B, Paulussen AD, Leter EM, Steijlen PM, Mosterd K, van Geel M, Gille JJ. New mutations and an updated database for the patched‐1 (PTCH 1) gene. Molecular genetics & genomic medicine. 2018 May;6(3):409-15.
3. Sim YC, Kim GH, Choi SW, Ahn KM. Novel PTCH1 gene mutation in nevoid basal cell carcinoma syndrome. Journal of Craniofacial Surgery. 2018 May 1;29(3):e252-5.
4. John AM, Schwartz RA. Basal cell naevus syndrome: an update on genetics and treatment. British journal of dermatology. 2016 Jan;174(1):68-76.
5. Alonso N, Cañueto J, Ciria S, Bueno E, Palacios‐Alvarez I, Alegre M, Badenas C, Barreiro A, Pena L, Maldonado C, Nespeira‐Jato MV. Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome. British Journal of Dermatology. 2018 Jan;178(1):198-206.